Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15
The FEBS Journal · 2024
DOI: 10.1111/febs.16992 ↗At a glance
Journal article in The FEBS Journal, 2024. Written by Sheng-Fan Wang and 8 co-authors. Institution: Department of Pharmacy, Taipei Veterans General Hospital, Taiwan. Major MEDLINE topics: Cisplatin, Stomach Neoplasms. Cited 20 times so far (Crossref); 112 references. Funded by: Melissa Lee Cancer Foundation, National Science and Technology Council, Taipei Veterans General Hospital.
Abstract (original language)
Gastric neoplasm is a high‐mortality cancer worldwide. Chemoresistance is the obstacle against gastric cancer treatment. Mitochondrial dysfunction has been observed to promote malignant progression. However, the underlying mechanism is still unclear. The mitokine growth differentiation factor 15 (GDF15) is a significant biomarker for mitochondrial disorder and is activated by the integrated stress response (ISR) pathway. The serum level of GDF15 was found to be correlated with the poor prognosis of gastric cancer patients. In this study, we found that high GDF15 protein expression might increase disease recurrence in adjuvant chemotherapy‐treated gastric cancer patients. Moreover, treatment with mitochondrial inhibitors, especially oligomycin (a complex V inhibitor) and salubrinal (an ISR activator), respectively, was found to upregulate GDF15 and enhance cisplatin insensitivity of human gastric cancer cells. Mechanistically, it was found that the activating transcription factor 4‐C/EBP homologous protein pathway has a crucial function in the heightened manifestation of GDF15. In addition, reactive oxygen species‐activated general control nonderepressible 2 mediates the oligomycin‐induced ISR, and upregulates GDF15. The GDF15–glial cell‐derived neurotrophic factor family receptor a‐like–ISR–cystine/glutamate transporter‐enhanced glutathione production was found to be involved in cisplatin resistance. These results suggest that mitochondrial dysfunction might enhance cisplatin insensitivity through GDF15 upregulation, and targeting mitokine GDF15–ISR regulation might be a strategy against cisplatin resistance of gastric cancer.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmacy, Taipei Veterans General Hospital, Taiwan.
- Department of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, Taiwan.
- Department and Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
ORCID profiles: Sheng-Fan Wang, Kuo-Hung Huang, Hsin-Chen Lee
Funding
- Melissa Lee Cancer Foundation
- National Science and Technology Council
- Taipei Veterans General Hospital
Cite
APA
Wang, S. F., Chang, Y. L., Liu, T. Y., Huang, K. H., Fang, W. L., Li, A. F., Yeh, T. S., Hung, G. Y., & Lee, H. C. (2024). Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15. The FEBS Journal. https://doi.org/10.1111/febs.16992
Vancouver
Wang SF, Chang YL, Liu TY, Huang KH, Fang WL, Li AF, et al. Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15. The FEBS Journal. 2024. doi:10.1111/febs.16992
BibTeX
@article{Wang2024,
author = {Wang, Sheng-Fan and Chang, Yuh-Lih and Liu, Ting-Yu and Huang, Kuo-Hung and Fang, Wen-Liang and Li, Anna Fen-Yau and Yeh, Tien-Shun and Hung, Giun-Yi and Lee, Hsin-Chen},
title = {Mitochondrial dysfunction decreases cisplatin sensitivity in gastric cancer cells through upregulation of integrated stress response and mitokine GDF15},
journal = {The FEBS Journal},
year = {2024},
doi = {10.1111/febs.16992}
}
EUVIMED